Press Release – Ora Pharm
As part of its global strategy, New Zealand medicinal cannabis company Ora Pharm has launched in Australia this week. Ora Pharm is the first New Zealand company in the Medicinal Cannabis space to export a branded product to an international market. …
As part of its global strategy, New Zealand medicinal cannabis company Ora Pharm has launched in Australia this week. Ora Pharm is the first New Zealand company in the Medicinal Cannabis space to export a branded product to an international market. Australia is the first export market entry by Ora Pharm and will build strong revenue streams through the sale of both dried flower and branded finished products.
With Australia experiencing exponentially exploding demand that is projected to account for 99 cents in every dollar of the USD $18.6bn (~€16.71) Oceania industrial hemp market in 2028, Ora Pharm is set to experience rapid growth.
Ora Pharm has developed patient-ready tincture formulations which are being manufactured and distributed by Canngea, one of Australia’s leading medical cannabis manufacturing and distribution companies, under strict GMP processes. Ora Pharm is also developing unique cannabis strains exclusively for Canngea.
Ora Pharm’s patient-ready oral solutions for both the Australian and New Zealand markets will be distributed via Canngea and ANSPEC which is one of the largest distributors of medicinal cannabis in Australia and has approximately 4,500 pharmacies on…
Original Author Link click here to read complete story..
Press Release – Ora Pharm
As part of its global strategy, New Zealand medicinal cannabis company Ora Pharm has launched in Australia this week. Ora Pharm is the first New Zealand company in the Medicinal Cannabis space to export a branded product to an international market. …
As part of its global strategy, New Zealand medicinal cannabis company Ora Pharm has launched in Australia this week. Ora Pharm is the first New Zealand company in the Medicinal Cannabis space to export a branded product to an international market. Australia is the first export market entry by Ora Pharm and will build strong revenue streams through the sale of both dried flower and branded finished products.
With Australia experiencing exponentially exploding demand that is projected to account for 99 cents in every dollar of the USD $18.6bn (~€16.71) Oceania industrial hemp market in 2028, Ora Pharm is set to experience rapid growth.
Ora Pharm has developed patient-ready tincture formulations which are being manufactured and distributed by Canngea, one of Australia’s leading medical cannabis manufacturing and distribution companies, under strict GMP processes. Ora Pharm is also developing unique cannabis strains exclusively for Canngea.
Ora Pharm’s patient-ready oral solutions for both the Australian and New Zealand markets will be distributed via Canngea and ANSPEC which is one of the largest distributors of medicinal cannabis in Australia and has approximately 4,500 pharmacies on…
